← Eichor
Study identifier: NCT07722715 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study on the Treatment of Dental Implants Using the AmbiJet System for Peri-implantitis and Peri-implant Mucositis

Condition: Peri Implant Mucositis · Peri Implantitis  ·  Sponsor: Freiburger Medizintechnik GmbH

PhaseNA
Planned participants26
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Inflammation of the tissue surrounding a dental implant (peri-implantitis or peri-implant mucositis) can lead to implant loss in advanced stages. The AmbiJet system utilizes cold atmospheric plasma (CAP), a physical procedure with a strong antibacterial effect. This clinical trial investigates whether the additional application of cold plasma directly on the patient following conventional mechanical cleaning of the implants is safe, well-tolerated, and resolves inflammation more quickly compared to standard treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Loic Ledernez, Phd  ·  +49 176 96127565  ·  ledernez@frmed.de

Always discuss trial participation with your own doctor first.

Locations (1)

LLC "Institute of Implantological ResearchRomny, UkraineRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07722715